Skip to main content

Table 1 Clinical sources of the glioma cell lines used in this study

From: Malignancy-associated metabolic profiling of human glioma cell lines using 1H NMR spectroscopy

Designation

Source (Tumor stage)

P53 gene mutation

CHG5

WHO II

Unknown

SHG44

WHO II

Wild-type[16]

U87

WHO IV

Wild-type[17]

U118

WHO IV

Mutation[18]

U251

WHO IV

Mutation[16]